Literature DB >> 9298325

Expression of ras proto-oncogenes: regulation and implications in the development of human tumors.

G Zachos1, D A Spandidos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9298325     DOI： 10.1016/s1040-8428(97)00013-9

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  6 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor alpha.

Authors:  C Solomon; J H White; R Kremer
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  Rapid development of salivary gland carcinomas upon conditional expression of K-ras driven by the cytokeratin 5 promoter.

Authors:  Ana R Raimondi; Lynn Vitale-Cross; Panomwat Amornphimoltham; J Silvio Gutkind; Alfredo Molinolo
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

4.  Inhibitory effects of caffeine analogues on neoplastic transformation: structure-activity relationship.

Authors:  Evgeny A Rogozin; Ki Won Lee; Nam Joo Kang; Haoyu Yu; Masaaki Nomura; Ken-Ichi Miyamoto; Allan H Conney; Ann M Bode; Zigang Dong
Journal:  Carcinogenesis       Date:  2008-01-14       Impact factor: 4.944

5.  Eicosapentaenoic acid activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells.

Authors:  Veronica Ceccarelli; Giuseppe Nocentini; Monia Billi; Serena Racanicchi; Carlo Riccardi; Rita Roberti; Francesco Grignani; Luciano Binaglia; Alba Vecchini
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

6.  The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer.

Authors:  Sabrina T Reis; Luciana S Timoszczuk; José Pontes-Junior; Nayara Viana; Iran A Silva; Nelson Dip; Miguel Srougi; Katia R M Leite
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.